Ignite Creation Date:
2025-12-25 @ 12:41 AM
Ignite Modification Date:
2025-12-27 @ 11:02 AM
Study NCT ID:
NCT01337167
Status:
COMPLETED
Last Update Posted:
2018-11-15
First Post:
2011-04-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-04-19
Start Date Type:
ACTUAL
Primary Completion Date:
2013-05-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-05-09
Completion Date Type:
ACTUAL
First Submit Date:
2011-04-15
First Submit QC Date:
None
Study First Post Date:
2011-04-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-02-18
Results First Submit QC Date:
None
Results First Post Date:
2016-03-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-19
Last Update Post Date:
2018-11-15
Last Update Post Date Type:
ACTUAL